Akari Therapeutics plc ADR (0.01 USD)

AKTX

...

AKTX: Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing inhibitors of acute and chronic inflammation which includes the complement system, the bioamine system and the eicosanoid system for the treatment of rare and orphan diseases. Its main product candidate includes Coversin, Coversin long acting and Coversin dual action. It operates mainly in United States and United Kingdom.

Show AKTX Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of AKTX by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

No Whale Activity for this ticker

Institutional Holdings Dashboard

Insider Trading

Quarterly net insider trading by AKTX's directors and management

No recent Insider Trading for this ticker

Insider Trading Dashboard

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

No new patents for this ticker

U.S. Patents Dashboard

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on AKTX's company Twitter account

WallStreetBets

Number of mentions of AKTX in WallStreetBets Daily Discussion

AKTX News

Recent insights relating to AKTX

CNBC Recommendations

Recent picks made for AKTX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in AKTX

Corporate Flights

Flights by private jets registered to AKTX